Director, Clinical Science

The Impact You’ll Make

Recursion is at the forefront of reimagining drug discovery by integrating automated cell biology, high-dimensional and diverse datasets, and sophisticated analytics. We are seeking a Director-level Clinical Scientist who can oversee all clinical aspects of a clinical trial(s). This includes planning and authoring clinical deliverables (protocols, amendments, medical monitoring plans, annual reports, study-specific updates, CSRs); routine medical monitoring; site interactions/correspondence regarding patient eligibility and treatment inquiries; and presentations, both internal and external.

Responsibilities

• Serve as the authoring lead on multiple clinical documents. Recursion is moving away from the use of Medical Writers and relying more heavily on the Clinical Scientist and Medical Director to author IND and study-specific documents, encompassing clinical documents and site/agency interactions.
• Collaborate with highly dynamic teams where your role will range from leading and owning decisions or timelines to being a key contributor whose experience and insight are relied upon to advance the task at hand.
• Drive and deliver the quality of your study data, including reviewing (Medical Monitoring); issuing, reviewing, and closing queries; reviewing TLFs, summarizing data throughout the trial, and presenting the data to management when requested.
• Present protocol procedures and Site Initiation Visits both in-person and virtually.
• Prioritize and support multiple early-phase (1-2) studies simultaneously, requiring strong time management and organizational skills.
• Interact cross-functionally with multiple disciplines supporting the Study Team (Clinical Operations, Medical Director, CMC, Data Management, CROs, CRAs, Investigative Sites, etc.).
• Review and clean/query pertinent data points, identifying trends or inconsistencies with the data, and serve as the face of the study to Investigative Sites.

Requirements

• 5-7+ years as a Clinical Scientist in a pharmaceutical or biotech company.
• Prior experience in early phase 1-2 oncology studies is required.
• Experience with hematologic malignancies is preferred.
• Strong interpersonal and communication skills (both spoken and written) with the ability to effectively communicate on project planning, progress, and tracking.
• Strong relationship-building skills to work effectively with others in various disciplines and levels.
• Proven ability to manage multiple, complex, and competing priorities to effective and efficient conclusion.
• Ability to operate strategically and tactically.
• Proven ability in problem-solving and issues management that is solution-focused.

About the Team

Reporting to the Vice President, Clinical Science, you’ll be joining the Clinical Science Team within Clinical Development. This group is ultimately responsible for shepherding an experimental drug from IND through Dose Finding, Proof of Concept, and possibly Registration studies. The team consists of high-performing, motivated individuals who work independently, interact cross-functionally with many contributing departments, and multitask to expeditiously execute cutting-edge clinical trials.

Pay

• New York City, Boston, & San Francisco Bay Area(s): $234,190–$287,980
• Salt Lake City & all other U.S. locations: $212,900–$261,800

In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

Schedule

This is a fully remote opportunity with occasional travel requirements. Travel may be necessary from time to time to support collaboration, team events, meetings, or other business needs.

Values

• We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
• We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
• We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
• We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
• We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
• We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation.